Carasent ASA has acquired Medrave Software AB. Medrave is a Scandinavian market leader in quality improvement software for healthcare practices within primary care and secondary outpatient care.
Medrave’s module-based software provides clinical reports to health care practices. The quality improvement solution automatically collects and sorts data, analyze and visualize, tracks and benchmarks KPIs, and provides automatic reporting. Medrave has a customer base of more than 260 clients across Sweden and Norway, covering 1,646 practices and an estimated 8.8 million patients.
Carasent ASA focuses on developing companies and e-health services in the Scandinavian market. The company is listed on the Oslo Stock Exchange.
Mannheimer Swartling advised Carasent ASA on legal matters in the transaction.